Insiders are selling even as outside money pours in
In the second quarter of 2025, at least six institutional investors quietly expanded their positions in Keysight Technologies, a maker of precision instruments for aerospace, defense, and semiconductor industries — a collective gesture of confidence in a company navigating the intersection of technological demand and market expectation. With 84% of shares held by institutions and analysts pointing toward a price target above current trading levels, the market's largest voices are leaning in. Yet beneath the optimism, company insiders have been selling, and at least one analyst has tempered enthusiasm — a reminder that conviction and caution often share the same moment.
- Six institutional investors poured fresh capital into Keysight during Q2 2025, with one firm nearly doubling its stake and two others opening brand-new positions, signaling broad Wall Street appetite for the stock.
- Keysight's Q2 earnings beat expectations — $1.72 EPS against forecasts, revenue up 11.1% year-over-year — giving institutional buyers a fundamental foundation for their confidence.
- While outside money flowed in, insiders quietly moved in the opposite direction: the CFO sold over 12,000 shares in late June, and a senior vice president followed in September, collectively offloading $2.38 million worth of stock.
- Analyst targets are climbing — JPMorgan raised its goal to $200 and called the stock overweight — but Wall Street Zen's downgrade and Bank of America's neutral stance introduce a note of measured restraint.
- Trading near $178, just below the consensus target of $187.38 and within a year-long range of $121 to $186, Keysight sits at a crossroads where the next few quarters will test whether institutional conviction holds.
Keysight Technologies, which builds electronic design and test equipment for aerospace, defense, semiconductor, and communications industries, has drawn a wave of institutional investment. During the second quarter of 2025, at least six firms expanded their stakes. Wealth Enhancement Advisory Services grew its position by 27.5%, while Baader Bank increased its holdings by 70.1%. Two firms — Financial Management Network and Sivia Capital Partners — opened entirely new positions. Together, these moves pushed institutional and hedge fund ownership to 84.58% of all outstanding shares.
The buying followed strong earnings. Keysight reported Q2 earnings per share of $1.72, beating analyst estimates by five cents, with revenue of $1.35 billion — up 11.1% from the prior year. Net margin stood at 10.36%, and return on equity reached 19.53%. On paper, the company looked healthy and growing.
But insiders told a quieter story. CFO Neil Dougherty sold over 12,000 shares in late June for roughly $2 million, trimming his stake by nearly 10%. A senior vice president followed in September. In total, insiders sold $2.38 million in shares during the same period that outside investors were accumulating — a tension that lingers without easy resolution.
Analyst opinion leaned bullish: JPMorgan raised its target to $200 with an overweight rating, while Bank of America moved its target modestly higher but held at neutral. Wall Street Zen stepped back from a strong buy to a simple buy. The consensus across seven analysts landed at a moderate buy, with an average target of $187.38 — above the stock's recent close of $178.36.
Keysight carries a market cap of $30.65 billion and trades at a price-to-earnings ratio of 56.80, a premium that reflects growth expectations. Management guided for full-year 2025 earnings of $7.09 per share, though analysts project a more modest $6.32. Whether the institutional enthusiasm reflects deep conviction or momentum chasing in a crowded growth sector may only become clear in the quarters ahead.
Keysight Technologies, the maker of electronic design and test equipment for aerospace, defense, semiconductors, and communications companies, has become a magnet for institutional money. During the second quarter of 2025, at least six separate investment firms expanded their stakes in the company, a coordinated show of confidence that suggests Wall Street's largest players see something worth owning.
NorthCrest Asset Management led the way with a modest 2.4% increase, adding 80 shares to bring its total position to 3,466 shares worth $579,000. But the real signal came from larger players. Wealth Enhancement Advisory Services nearly doubled down, growing its stake by 27.5%—buying 3,501 additional shares to reach a position worth $2.7 million. Baader Bank Aktiengesellschaft was even more aggressive, expanding its holdings by 70.1%, adding 1,206 shares. Two other firms, Financial Management Network and Sivia Capital Partners, opened entirely new positions in Keysight during the quarter, committing $217,000 and $254,000 respectively. Mn Services Vermogensbeheer B.V., a Dutch asset manager, added another 800 shares. Taken together, these moves reflect a broader institutional embrace of the company—84.58% of Keysight's stock is now held by hedge funds and institutional investors.
The buying spree arrived on the heels of solid earnings. In August, Keysight reported second-quarter earnings per share of $1.72, beating analyst expectations by five cents. Revenue came in at $1.35 billion, also ahead of forecasts and up 11.1% from the same quarter the year before. The company's net margin sits at 10.36%, and it generated a 19.53% return on equity. On the surface, these are the numbers of a company firing on all cylinders.
Yet the picture is more complicated. While institutional investors were buying, company insiders were selling. In late June, Chief Financial Officer Neil Dougherty sold 12,215 shares at an average price of $164.60, netting roughly $2 million and reducing his stake by 9.58%. In mid-September, Senior Vice President Ingrid Estrada sold 2,000 shares at $173.98 each. Over the preceding three months, insiders had collectively sold 14,357 shares worth $2.38 million. Insiders still own 0.61% of the company, a small but not insignificant stake, and their selling—even as outside money poured in—raises a quiet question about what they know that the market doesn't.
Analyst sentiment has turned decidedly bullish, though not uniformly so. JPMorgan Chase raised its price target from $177 to $200 and assigned an "overweight" rating. Bank of America lifted its target from $175 to $179, though it stopped short of enthusiasm, assigning a "neutral" rating. Barclays kept an "overweight" rating but trimmed its target from $200 to $195. Wall Street Zen, however, downgraded the stock from "strong buy" to "buy," a notable step back. Across the analyst community, seven firms rate the stock a buy and one rates it a hold, giving Keysight a consensus "moderate buy" rating with an average price target of $187.38.
Keysight closed Friday trading at $178.36, having traded as low as $121.43 and as high as $186.20 over the past year. The company carries a market capitalization of $30.65 billion and trades at a price-to-earnings ratio of 56.80—a premium valuation that reflects growth expectations. Management has guided for fourth-quarter earnings between $1.79 and $1.85 per share, with full-year 2025 guidance at $7.09 per share. Analysts expect the company to earn $6.32 per share for the current fiscal year, suggesting some moderation ahead.
What emerges is a portrait of a company at an inflection point. Institutional investors see value and are accumulating shares. Earnings are beating expectations and revenue is growing at double-digit rates. Yet insiders are trimming positions, and at least one analyst has stepped back from maximum enthusiasm. The stock trades near the middle of its 52-week range, neither cheap nor expensive by recent standards. For investors watching Keysight, the next few quarters will determine whether the institutional buying represents genuine conviction or merely the momentum of capital seeking growth in a crowded sector.
Notable Quotes
Keysight reported second-quarter earnings per share of $1.72, beating analyst expectations by five cents, with revenue up 11.1% year-over-year.— Company earnings report, August 2025
JPMorgan Chase raised its price target from $177 to $200 and assigned an overweight rating.— JPMorgan Chase analyst report, July 2025
The Hearth Conversation Another angle on the story
Why are so many institutional investors buying Keysight right now? What's the catalyst?
The earnings beat in August seems to have opened eyes. They came in five cents ahead of expectations and grew revenue 11.1% year-over-year. That's the kind of execution that gets attention from large portfolio managers.
But insiders are selling. Doesn't that worry you?
It should. The CFO sold $2 million worth of shares in June, and the senior VP followed suit in September. Insiders don't usually sell into strength unless they think the stock has run ahead of fundamentals.
The stock trades at a P/E of 56. That's expensive.
Very expensive. You're paying for growth that has to keep accelerating. If Keysight stumbles even slightly, that valuation compresses fast.
So why are the institutions buying if the price is so high?
Because they're looking at the business—aerospace, defense, semiconductors, communications. These are secular growth markets. And Keysight has 84% institutional ownership already. Once you're that embedded in the index funds and large portfolios, momentum can be self-reinforcing.
What would break this story?
A miss on earnings. Or guidance that suggests the growth rate is slowing. The company is guiding for $7.09 in full-year earnings, but analysts only expect $6.32. That gap suggests either conservatism or trouble ahead.